Pancreaticoduodenal tumors develop in a majority of patients with multiple endocrine
neoplasia type 1 (MEN 1) and have a pronounced effect on life expectancy as the principal …

Multiple endocrine neoplasia type 1 (MEN1) is classically characterized by the development
of functional or nonfunctional hyperplasia or tumors in endocrine tissues (parathyroid …

Multiple endocrine neoplasia type 1 (MEN1) provides a prime example of how a rare
disease can advance our understanding of basic cell biology, neoplasia and common …

In patients with multiple endocrine neoplasia type 1 (MEN1), the most common functional
pancreatic endocrine tumor (PET) syndrome is Zollinger-Ellison syndrome (ZES). ZES has …

Objective: To report long-term follow-up of patients with multiple endocrine neoplasia type 1
(MEN1) and nonfunctioning pancreatic neuroendocrine tumors (NF-PET). Background …

Neuroendocrine neoplasms (NENs) are rare neoplasms that occur in various organs and
present with diverse clinical manifestations. Pathological classification is important in the …

Multiple endocrine neoplasia type 1 (MEN1), a rare tumor syndrome that is inherited in an
autosomal dominant pattern, is continuing to raise great interest for endocrinology …

Background. The management of pancreaticoduodenal endocrine tumors (PETs) remains
controversial in multiple endocrine neoplasia type 1 (MEN 1). Methods. Twenty-one patients …

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal syndrome caused by mutations
in the MEN1 tumor suppressor gene. Whereas the protein product of MEN1, menin, is …

Metastatic duodenopancreatic neuro-endocrine tumors (dpNETs) are the most important
disease-related cause of death in patients with multiple endocrine neoplasia type 1 (MEN1) …